New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Abstract Title: Biomarker analysis from Phase 2 study of AgenT-797 (invariant natural killer T-cells), botensilimab (a Fc-enhanced CTLA-4 Inhibitor) with balstilimab (anti-PD-1) in PD-1 refractory ...

To encourage industry dialog and collaboration, the event is inviting scholars and professionals worldwide to submit research papers and nominate speakers for oral presentations at the special events ...

Denise Sandoval, who has taught at Cal State Northridge since 2002, is perhaps the premier scholar on lowrider culture and ...

Ganesan argues that students should use AI intelligently while preserving their critical thinking skills, advocating for its ...

Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...

Good morning, everyone, and welcome to the Anavex Life Sciences Fiscal 2025 First Quarter Conference Call. My name is Clint ...

Shepherd University’s athletes will soon be some of the subjects of a new study being conducted by Photobiomodulation (PBM) ...

Anterior Cruciate Ligament Reconstruction Improves Functional Scores and Quality of Life in Patients Older than 50 Years of ...

The American Association for Cancer Research Annual Meeting 2025 will be held from April 25-30 in Chicago, Illinois, providing a ...

Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...